Business Combination (Details) (Licensing Agreements [Member], USD $)			0 Months Ended	1 Months Ended	3 Months Ended
	Jun. 30, 2014	Jun. 06, 2013	Jun. 06, 2013 Access Pharmaceuticals Inc [Member]	Jun. 30, 2013 Access Pharmaceuticals Inc [Member]	Jun. 30, 2013 Access Pharmaceuticals Inc [Member]
Business Combination
Upfront payment in consideration of license				$ 3,300,000
Consideration:
Cash			3,434,000
Acquisition-related contingent consideration			13,700,000
Total consideration			17,134,000
Assets Acquired
Acquired finite-lived intangible assets	16,700,000	16,900,000	16,893,000
Inventory			241,000
Net identifiable assets acquired			17,134,000
Acquisition-related costs					$ 800,000